Search clinical trials for: Insulin clamp

Total 3176 results

Hillerod Hospital, Denmark
Rigshospitalet, Denmark; University of Southern Denmark; UNEEG Medical A/S

Completed

Recurrent Hypoglycaemia in Type 1 Diabetes (HypoNeuro)

Hypoglycaemia

Denmark
The Cleveland Clinic

Completed

Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery

Cardiac Surgery

United States, Canada
Pennington Biomedical Research Center

Recruiting

Effect of Pulsatile Hormone Administration on Insulin Action

Insulin Sensitivity

United States
Fundación para la Investigación del Hospital Clínico...
Universitat Politècnica de València

Completed

Effect of Different Plasma Insulin Levels on the Accuracy of Continuous Subcutaneous Glucose Monitoring

Hypoglycemia | Type 1 Diabetes | Continuous Glucose Monitoring

Spain
National Institute of Neurological Disorders and...

Completed

Reduced Manipulation of the Aorta and Neurobehavioral Outcome Trial

Coronary Disease

United States
Brigham and Women's Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Beth... and other collaborators

Completed

Hypoglycemia and Autonomic Nervous System Function (HypoANS)

Hypoglycemia

United States
Adocia
Tonghua Dongbao Pharmaceutical Co.,Ltd

Completed

A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes

Type 1 Diabetes

Germany
University of Aarhus

Completed

Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics

Obesity | Dyslipidemia

Denmark
Shanghai Jiao Tong University School of Medicine

Suspended

CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation

Leukemia

China
Merck Sharp & Dohme LLC

Completed

Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168)

Diabetes
University of Hull
Hull University Teaching Hospitals NHS Trust

Completed

The Effects of Hypoglycaemia in People With Type 2 Diabetes

Type 2 Diabetes Mellitus

United Kingdom
Adocia
Tonghua Dongbao Pharmaceutical Co.,Ltd

Completed

A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and Lantus® in Healthy Chinese Volunteers

Healthy

Germany
Adocia
Tonghua Dongbao Pharmaceutical Co.,Ltd

Completed

A Trial Investigating the Dose Linearity and Safety of BC Combo THDB0207 in Subjects With Type 2 Diabetes

Type 2 Diabetes

Germany
University of Copenhagen

Recruiting

Insulin Sensitivity After Breast Cancer

Breast Cancer | Insulin Sensitivity/Resistance | Metabolic Disturbance | Survivorship

Denmark
McGill University Health Centre/Research Institute...

Unknown

High Dose Insulin Therapy to Improve Liver Function

Hepatitis C Virus

Canada
Emory University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Stroke Study: Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery

Stroke

United States
Pennington Biomedical Research Center

Enrolling by invitation

Effect of Physiologic Insulin Administration on Cognition

Alzheimer Disease

United States
University of Illinois College of Medicine at Peoria
OSF Healthcare System

Unknown

Nasogastric Tube Clamping Trial vs. Immediate Removal

Ileus | Small Bowel Obstruction

United States
Boston Children's Hospital
Beth Israel Deaconess Medical Center; Brigham and Women's Hospital

Completed

Dietary Glycemic Index, Brain Function and Food Intake in Patients With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

United States
University of Aarhus
Aarhus University Hospital; University of Copenhagen; Lundbeck Foundation; Vejle... and other collaborators

Completed

Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders

Obesity | Diabetes Mellitus | Metabolic Syndrome | Hyperlipidemia | Arterial Hypertension

Denmark
Indonesia University

Unknown

The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus

Diabetes Mellitus

Indonesia
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States

Diabetes | Malnutrition; Diabetes
TriHealth Inc.

Completed

Gomco Versus Mogen: Which is Best? A Randomized Controlled Trial (GMRT)

Circumcision, Male

United States
ikfe-CRO GmbH
IKFE Institute for Clinical Research and Development

Unknown

Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use

Insulin-requiring Type 2 Diabetes Mellitus

Germany
I.M. Sechenov First Moscow State Medical University

Recruiting

The Evaluation of Functional Parenchymal Volume and Split Renal Function Before and After Partial Nephrectomy

Renal Cell Carcinoma

Russian Federation
Sanofi

Completed

Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes (SPIRIT)

Type 2 Diabetes Mellitus

Ukraine
Geropharm

Completed

Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

Russian Federation
Novo Nordisk A/S

Completed

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes (BOOST)

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

United States, Puerto Rico
Novo Nordisk A/S

Completed

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan

Diabetes Mellitus, Type 2 | Diabetes

United Arab Emirates, Malaysia, India, South Africa, Algeria, Lebanon
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Austria, Switzerland, United Kingdom, Germany, Ireland
Novo Nordisk A/S

Completed

Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Saudi Arabia, Egypt
Brigham and Women's Hospital
Beth Israel Deaconess Medical Center; Boston Children's Hospital; Mclean Hospital

Recruiting

The Functional Neuroanatomy of the Human Physiological Stress Response (Hypo fMRI)

Hypoglycemia | Physiological Stress

United States
Novo Nordisk A/S

Completed

Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Denmark, Sweden, Norway
Novo Nordisk A/S

Completed

Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.

Diabetes Mellitus, Type 2 | Diabetes

Japan
Heidelberg University

Completed

Glucose-dependent Asprosin Dynamics

Diabetes Mellitus

Germany
Novo Nordisk A/S

Completed

Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes (PreFER)

Diabetes Mellitus, Type 2 | Diabetes

Austria, Germany, Switzerland
Novo Nordisk A/S

Completed

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes (UPGRADE)

Diabetes Mellitus, Type 2 | Diabetes

Italy
Novo Nordisk A/S

Completed

Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Denmark
Novo Nordisk A/S

Completed

Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Poland, Spain, Germany, Finland, France
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

China
CPEX Pharmaceuticals Inc.

Completed

Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus (CPEX-011)

Type 2 Diabetes

United States
Novo Nordisk A/S

Completed

Comparison of Two Formulations of Biphasic Insulin Aspart 70

Healthy | Diabetes

United Kingdom
Emory University
Sanofi; University of Miami

Completed

Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes

Hyperglycemia | Diabetes

United States
Novo Nordisk A/S

Completed

Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany, Poland, Russian Federation, Spain, Sweden, Netherlands, Singapore, Malaysia, France, Croatia, Romania, United Kingdom, Hong Kong
University of Ljubljana, Faculty of Medicine

Completed

The Influence of Acute Hyperglycaemia on Brain in T1D

Hyperglycemia | Type 1 Diabetes Mellitus

Slovenia
Novo Nordisk A/S

Completed

Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication (A1chieve®)

Diabetes Mellitus, Type 2 | Diabetes

Saudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
Novo Nordisk A/S

Completed

Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

United Kingdom, France, Netherlands, Belgium, Ireland
Novo Nordisk A/S

Completed

Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

Diabetes Mellitus, Type 2 | Diabetes

Turkey

Search clinical trials for: Insulin clamp

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations